Dianthus Therapeutics, Inc. earnings per share and revenue

A3ERZ4 earnings per share for the last quarter are -0.66 EUR whereas the estimation was -0.53 EUR which accounts for -24.45% surprise. Company revenue for the same period amounts to 1.95 M EUR despite the estimated figure of 665.65 k EUR. Estimated earnings per share for the next quarter are -0.82 EUR, and revenue is expected to reach 922.72 k EUR. Also watch annual changes over time to get a bigger picture of A3ERZ4 earnings per share and revenue dynamics.